Last updated 2026-07-26
- Raised $6.7M Undisclosed Round, Jun 2016
- Raised $924k grant, Apr 2023
- Raised $2.5M Undisclosed Round, Jan 2013
Total raised
$10.1M
Last: Undisclosed Round 2016-06
Stage
Series B
Founded
2012
Headcount
7
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
TargetGene Biotechnologies is an innovative biotechnology company focused on creating efficient and supremely specific DNA editing solutions in living organisms. The company's R&D is centered around its patented and patent-pending "T•GEE" (Genome Editing Engine) platform, which is the first to invent RNA-guided gene-targeting. TargetGene aims to implement the T•GEE platform for human gene therapy, with a focus on inherited diseases, cell-based immunotherapy, cancer, and autoimmune disorders. The platform utilizes two guide RNAs and an obligatory dimeric nuclease to achieve high specificity and lower off-target events compared to CRISPR/Cas9.
Funding history · 4 rounds · $10.1M total
2023-04
Grant
$924K
reconcile
2019
Grant
Undisclosed
reconcile
2016-06
Undisclosed Round
$6.7M
reconcile
2013-01
Undisclosed Round
$2.5M
reconcile
Headcount over time
From 9 (2018-07) to 6 (2025-12) · -3 (-33%) · 22 points · source: Finder history + radar grounding
Q&A
- What is TargetGene Biotechnologies' primary focus?
- TargetGene Biotechnologies focuses on creating efficient and specific DNA editing solutions in living organisms, with R&D centered on its patented and patent-pending TGEE (genome editing engine) platform.
- When was TargetGene Biotechnologies founded?
- TargetGene Biotechnologies was founded in October 2012.
- What is the total amount of funding TargetGene Biotechnologies has raised?
- TargetGene Biotechnologies has raised a total of $9,200,000 USD.
- Which investors participated in TargetGene Biotechnologies' June 2016 funding round?
- In June 2016, Monsanto participated in a funding round for TargetGene Biotechnologies.
- What is TargetGene Biotechnologies' current employee count?
- TargetGene Biotechnologies has 1-10 employees.
- What is the primary sector of TargetGene Biotechnologies?
- TargetGene Biotechnologies operates in the Health Tech & Life Sciences sector.
- What is the company's strategic goal for its TGEE platform?
- TargetGene Biotechnologies aims to implement its TGEE platform for human gene therapy, specifically focusing on inherited diseases and cell-based immunotherapy.
- Does TargetGene Biotechnologies hold any patents?
- Yes, TargetGene Biotechnologies holds patents and has patent-pending technology.
Team · 2
Dan Weinthal
Founder · Co-founder, COO
Yoel Shiboleth
Founder · Co-founder, CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
laboratoriesmedical-technologiesbiotechnologygenomicsgenetic-engineeringacademiageneticspatent-pending
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | targetgenebio.com |
|---|---|
| linkedin.com/company/3216766 | |
| YouTube | youtube.com/channel/UCfX49fh4T07F1Of1m1BLVnw |
Identifiers & details
| Legal name | TARGETGENE BIOTECHNOLOGIES LTD |
|---|---|
| Founded | 2012-10 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | targetgenebio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 5 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514820604 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-09-13 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 8 — shares_capital (1), annual_report (4), people (3) |
| Registered address | שביל טיילת 0 מגל |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-15 | העברת מניות |
| 2026-02-10 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-02-10 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-02-10 | דו~ח שנתי-עדכון כתובת |
| 2026-02-10 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-01-01 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-01 | עדכון דירקטורים-הסרת דירקטור |
| 2026-01-01 | עדכון בעלי תפקידים |